Nanosphere is preparing to launch a diagnostic system that uses nanoparticles to detect various proteins at a level of sensitivity never before seen.

Nanosphere hopes to have a prostate-specific antigen screen ready by next year for breast and ovarian cancer as well as prostate cancer.